Clinical trials for anal cancer
24 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial

Phase 3
Anal cancer
#NCT06207981
Locally Advanced
Radiotherapy
Radiotherapy
CHU - Haut-Lévêque - Bordeaux (Pessac), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Hôpital Privé Sainte Marie - Ramsay Santé (Chalon-sur-Saône), Institut de Cancérologie des Hauts-de-France - Centre Marie Curie (Arras), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon) (and 1 more...)
Fédération Francophone de Cancérologie Digestive
Phase 2
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Stomach and esophageal cancer
#NCT05325866
Adenocarcinoma
Metastatic
Metastatic Castration-resistant
FGFR
1
2
3 or more
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 3 more...)
Amgen
Phase 2
#NCT02628067
Locally Advanced
Metastatic
Metastatic Castration-resistant
MSI/dMMR
1
2
3 or more
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Besançon (Besançon), IUCT Oncopôle (Toulouse), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain) (and 4 more...)
Merck Sharp & Dohme LLC
Phase 2
#NCT02628067
Locally Advanced
Metastatic
Metastatic Castration-resistant
1
2
3 or more
MSI/dMMR
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Gustave Roussy (Villejuif), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 4 more...)
Merck Sharp & Dohme LLC
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05751798
Locally Advanced
Metastatic
Metastatic Castration-resistant
MSI/dMMR
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
#NCT05503797
Locally Advanced
Metastatic
BRAF
1
2
3 or more
HRAS
KRAS G12C
KRAS non G12C
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 2 more...)
Fore Biotherapeutics
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT05503797
Neuroendocrine tumor
Locally Advanced
Metastatic
BRAF
1
2
3 or more
HRAS
KRAS G12C
KRAS non G12C
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 2 more...)
Fore Biotherapeutics
Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux) (and 2 more...)
PMV Pharmaceuticals, Inc
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
Endometrial cancer
#NCT06760819
Clear cell carcinoma
Stomach
Oesogastric junction
Esophagus
Adenocarcinoma
Other
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Ampullary carcinoma
Gastrointestinal stromal tumor
Squamous cell carcinoma
HER2 Positive
Locally Advanced
Metastatic
Metastatic Castration-resistant
HER2
1
Systemic Treatment-Naive
Centre Oscar Lambret (Lille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut Bergonié (Bordeaux)
Bayer
Phase 2
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT06475352
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Centre Hospitalier de la Côte Basque (Bayonne) (and 28 more...)
UNICANCER